These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 21425964)
1. Challenges faced in choosing novel targets to treat chronic pain. Henze DA Future Med Chem; 2009 May; 1(2):231-5. PubMed ID: 21425964 [No Abstract] [Full Text] [Related]
2. Hot receptors in the brain. Steenland HW; Ko SW; Wu LJ; Zhuo M Mol Pain; 2006 Nov; 2():34. PubMed ID: 17092351 [TBL] [Abstract][Full Text] [Related]
3. Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway. Gunthorpe MJ; Chizh BA Drug Discov Today; 2009 Jan; 14(1-2):56-67. PubMed ID: 19063991 [TBL] [Abstract][Full Text] [Related]
4. TRPV1 antagonists: the challenges for therapeutic targeting. Khairatkar-Joshi N; Szallasi A Trends Mol Med; 2009 Jan; 15(1):14-22. PubMed ID: 19097938 [TBL] [Abstract][Full Text] [Related]
5. Identification and biological characterization of 6-aryl-7-isopropylquinazolinones as novel TRPV1 antagonists that are effective in models of chronic pain. Culshaw AJ; Bevan S; Christiansen M; Copp P; Davis A; Davis C; Dyson A; Dziadulewicz EK; Edwards L; Eggelte H; Fox A; Gentry C; Groarke A; Hallett A; Hart TW; Hughes GA; Knights S; Kotsonis P; Lee W; Lyothier I; McBryde A; McIntyre P; Paloumbis G; Panesar M; Patel S; Seiler MP; Yaqoob M; Zimmermann K J Med Chem; 2006 Jan; 49(2):471-4. PubMed ID: 16420034 [TBL] [Abstract][Full Text] [Related]
6. Transient receptor potential vanilloid-1 antagonists: a survey of recent patent literature. Voight EA; Kort ME Expert Opin Ther Pat; 2010 Sep; 20(9):1107-22. PubMed ID: 20586701 [TBL] [Abstract][Full Text] [Related]
7. Current and emerging targets to treat neuropathic pain. Butera JA J Med Chem; 2007 May; 50(11):2543-6. PubMed ID: 17489576 [No Abstract] [Full Text] [Related]
8. [The TRPV1 channel as a target for the treatment of pain]. Salazar H; Jara-Oseguera A; Rosenbaum T Rev Neurol; 2009 Apr 1-15; 48(7):357-64. PubMed ID: 19319817 [TBL] [Abstract][Full Text] [Related]
9. [Tapentadol. Opioid analgesic and norepinephrine reuptake inhibitors]. Weichel C; Hecht B Med Monatsschr Pharm; 2010 Dec; 33(12):454-60. PubMed ID: 21189520 [No Abstract] [Full Text] [Related]
10. TRPV1: a therapeutic target for novel analgesic drugs? Szallasi A; Cruz F; Geppetti P Trends Mol Med; 2006 Nov; 12(11):545-54. PubMed ID: 16996800 [TBL] [Abstract][Full Text] [Related]
11. The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain. Westaway SM J Med Chem; 2007 May; 50(11):2589-96. PubMed ID: 17489570 [No Abstract] [Full Text] [Related]
12. Transient receptor potential vanilloid channels functioning in transduction of osmotic stimuli. Liedtke W J Endocrinol; 2006 Dec; 191(3):515-23. PubMed ID: 17170210 [TBL] [Abstract][Full Text] [Related]
13. Progressive neurodegenerative disease and pain. Shah S; Tear S IDrugs; 2005 Dec; 8(12):957-9. PubMed ID: 16320119 [No Abstract] [Full Text] [Related]
15. Pyrido[2,3-b]pyrazines, discovery of TRPV1 antagonists with reduced potential for the formation of reactive metabolites. Hodgetts KJ; Blum CA; Caldwell T; Bakthavatchalam R; Zheng X; Capitosti S; Krause JE; Cortright D; Crandall M; Murphy BA; Boyce S; Brian Jones A; Chenard BL Bioorg Med Chem Lett; 2010 Aug; 20(15):4359-63. PubMed ID: 20615696 [TBL] [Abstract][Full Text] [Related]
16. Feedback mechanisms in the regulation of intracellular calcium ([Ca2+]i) in the peripheral nociceptive system: role of TRPV-1 and pain related receptors. Hagenacker T; Ledwig D; Büsselberg D Cell Calcium; 2008 Mar; 43(3):215-27. PubMed ID: 17673288 [TBL] [Abstract][Full Text] [Related]
17. Neuroscience: a local route to pain relief. McCleskey EW Nature; 2007 Oct; 449(7162):545-6. PubMed ID: 17914381 [No Abstract] [Full Text] [Related]
18. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks. Wong GY; Gavva NR Brain Res Rev; 2009 Apr; 60(1):267-77. PubMed ID: 19150372 [TBL] [Abstract][Full Text] [Related]
19. Signal transduction in chronic pain. Wu J; Li J; Lin Q; Fang L Int Anesthesiol Clin; 2007; 45(2):73-81. PubMed ID: 17426509 [No Abstract] [Full Text] [Related]
20. Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia. Nagakura Y; Oe T; Aoki T; Matsuoka N Pain; 2009 Nov; 146(1-2):26-33. PubMed ID: 19646816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]